Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma. [PDF]
Kurzinski KL, Zigler CK, Torok KS.
europepmc +1 more source
Dental care in scleroderma – What should we know about scleroderma?
Scleroderma is a disease of the connective tissue that is characterized by autoimmune reactions, excess collagen deposition and vascular hyperactivity and phenomena. It can affect virtually anyone at any age although having a predisposition towards women
Theos, Papaefstathiou
core
Background. The aim of this project is to perform immunophenotyping of patients with JLS and healthy controls to assess dysregulated immunological pathways in JLS, and to identify biomarkers able to predict clinical features. Methods.
Società Italiana di Reumatologia
doaj
Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]
Sander L +5 more
europepmc +1 more source
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. [PDF]
Torok KS +7 more
europepmc +1 more source
IL-17 Signaling Inhibitors in Localized Scleroderma: A Single-Center Case Series of Nine Patients. [PDF]
Takahashi T +5 more
europepmc +1 more source
Successful Treatment of Localized Scleroderma in Intertriginous Areas with Tofacitinib: A Case Report. [PDF]
Xu D, Qian S, Tang Y, Bao W, Xu J.
europepmc +1 more source
Methotrexate in juvenile localized scleroderma: Adding to the evidence [PDF]
openaire +1 more source
Macrophage-fibroblast signaling networks identified by single-cell RNA sequencing in juvenile systemic sclerosis. [PDF]
Shethji A +5 more
europepmc +1 more source

